Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 8/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 3/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 3/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.39 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.39 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1009313 | 0.95 | GNAI3 (0.44) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| SCHEMBL19366459 | 0.95 | KDM1A (0.44) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| Hydrochloric Acid SCHEMBL4796821 | 0.93 | GNAI3 (0.47) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| SCHEMBL27804953 | 0.91 | GNAI3 (0.41) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| SCHEMBL3307772 | 0.91 | GNAI3 (0.41) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| SCHEMBL2673338 | 0.89 | EPHX1 (0.44) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| SCHEMBL13838034 | 0.89 | RAD52 (0.47) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| SCHEMBL27911707 | 0.87 | KDM1A (0.44) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| SCHEMBL5868679 | 0.85 | GNAI3 (0.38) | KDM1AMAOBMAOAGNAI3GNAO1 | |
| SCHEMBL1587227 | 0.85 | GNAI3 (0.38) | KDM1AMAOBMAOAGNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7098219-B2 | Quinolone derivatives | WOCKHART LIMITED (IN) | 2006-08-29 | — | — | US | disclosed |
| EP-1305048-A2 | INHIBITORS OF CELLULAR EFFLUX PUMPS OF MICROBES | Wockhardt Limited (IN) | 2003-05-02 | — | — | EP | disclosed |
| US-20020177559-A1 | Quinolone derivatives | WOCKHARDT LIMITED | 2002-11-28 | — | — | US | disclosed |
| WO-2002009758-A2 | INHIBITORS OF CELLULAR EFFLUX PUMPS OF MICROBES | WOCKHARDT LIMITED (IN) | 2002-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020177559-A1 | Quinolone derivatives | ABCB11, ABCB1, ABCG2 | KDM1A 3785/4885MAOB 1563/4885MAOA 1829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.